Bukreyeva N[au] - Search Results

Year	Number of Results
1999	1
2017	1
2018	2
2019	4
2020	4
2022	0

1

Zika virus infection elicits auto-antibodies to C1q.

Koma T, Veljkovic V, Anderson DE, Wang LF, Rossi SL, Shan C, Shi PY, Beasley DW, Bukreyeva N, Smith JN, Hallam S, Huang C, von Messling V, Paessler S. Koma T, et al. Among authors: bukreyeva n. Sci Rep. 2018 Jan 30;8(1):1882. doi: 10.1038/s41598-018-20185-8. Sci Rep. 2018. PMID: 29382894 Free PMC article.

2

Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection.

Mantlo E, Bukreyeva N, Maruyama J, Paessler S, Huang C. Mantlo E, et al. Among authors: bukreyeva n. bioRxiv. 2020 Apr 5:2020.04.02.022764. doi: 10.1101/2020.04.02.022764. Preprint. bioRxiv. 2020. PMID: 32511327 Free PMC article. Updated.

3

Fentanyl self-administration impacts brain immune responses in male Sprague-Dawley rats.

Ezeomah C, Cunningham KA, Stutz SJ, Fox RG, Bukreyeva N, Dineley KT, Paessler S, Cisneros IE. Ezeomah C, et al. Among authors: bukreyeva n. Brain Behav Immun. 2020 Jul;87:725-738. doi: 10.1016/j.bbi.2020.03.003. Epub 2020 Mar 9. Brain Behav Immun. 2020. PMID: 32165150

4

Antiviral activities of type I interferons to SARS-CoV-2 infection.

Mantlo E, Bukreyeva N, Maruyama J, Paessler S, Huang C. Mantlo E, et al. Among authors: bukreyeva n. Antiviral Res. 2020 Jul;179:104811. doi: 10.1016/j.antiviral.2020.104811. Epub 2020 Apr 29. Antiviral Res. 2020. PMID: 32360182 Free PMC article.

5

In vitro anti-influenza activity of in silico repurposed candidate drug cycrimine.

Matejin S, Bukreyeva N, Radosevic D, Sencanski M, Mantlo E, Veljkovic V, Glisic S, Paessler S. Matejin S, et al. Among authors: bukreyeva n. Antivir Ther. 2019;24(8):589-593. doi: 10.3851/IMP3348. Antivir Ther. 2019. PMID: 32108589

6

Catching and killing of airborne SARS-CoV-2 to control spread of COVID-19 by a heated air disinfection system.

Yu L, Peel GK, Cheema FH, Lawrence WS, Bukreyeva N, Jinks CW, Peel JE, Peterson JW, Paessler S, Hourani M, Ren Z. Yu L, et al. Among authors: bukreyeva n. Mater Today Phys. 2020 Dec;15:100249. doi: 10.1016/j.mtphys.2020.100249. Epub 2020 Jul 7. Mater Today Phys. 2020. PMID: 34173438 Free PMC article.

7

Virtual Screen for Repurposing of Drugs for Candidate Influenza a M2 Ion-Channel Inhibitors.

Radosevic D, Sencanski M, Perovic V, Veljkovic N, Prljic J, Veljkovic V, Mantlo E, Bukreyeva N, Paessler S, Glisic S. Radosevic D, et al. Among authors: bukreyeva n. Front Cell Infect Microbiol. 2019 Mar 26;9:67. doi: 10.3389/fcimb.2019.00067. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 30972303 Free PMC article.

8

Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens.

Tong X, Smith J, Bukreyeva N, Koma T, Manning JT, Kalkeri R, Kwong AD, Paessler S. Tong X, et al. Among authors: bukreyeva n. Antiviral Res. 2018 Jan;149:34-40. doi: 10.1016/j.antiviral.2017.11.004. Epub 2017 Nov 8. Antiviral Res. 2018. PMID: 29126899

9

Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.

Maruyama J, Mateer EJ, Manning JT, Sattler R, Seregin AV, Bukreyeva N, Jones FR, Balint JP, Gabitzsch ES, Huang C, Paessler S. Maruyama J, et al. Among authors: bukreyeva n. Vaccine. 2019 Oct 23;37(45):6824-6831. doi: 10.1016/j.vaccine.2019.09.030. Epub 2019 Sep 24. Vaccine. 2019. PMID: 31561999 Free PMC article.

10

Lethal Infection of Lassa Virus Isolated from a Human Clinical Sample in Outbred Guinea Pigs without Adaptation.

Maruyama J, Manning JT, Mateer EJ, Sattler R, Bukreyeva N, Huang C, Paessler S. Maruyama J, et al. Among authors: bukreyeva n. mSphere. 2019 Sep 25;4(5):e00428-19. doi: 10.1128/mSphere.00428-19. mSphere. 2019. PMID: 31554720 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results